Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation
NCT02594345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2016-02-23
Summary
This study is designed to analyze the effect exosomes derived from red blood cell units have on blood coagulation and platelet function. It is an in vitro study using healthy volunteers' blood.
Conditions
- Blood Coagulation
- Platelet Function
Interventions
- OTHER
-
in vitro study
Exosomes will be mixed with healthy volunteers' blood in vitro
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Dania P Fischer, M.D. · Goethe University
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
NCT04776239 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes
NCT03343782 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects
NCT02886884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients
NCT03943940 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Study for Patients With Heart Disease
NCT00221182 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
NCT01903044 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia
NCT03455335 ·Status: COMPLETED ·Phase: PHASE1
-
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
NCT02504437 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
NCT00922389 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
NCT06364150 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
NCT01442129 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
NCT02993809 ·Status: UNKNOWN ·Phase: PHASE1
-
The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
NCT06224296 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
NCT01028794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery
NCT05669144 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic Patients
NCT00677404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
NCT06321198 ·Status: RECRUITING ·Phase: NA
-
Collection of Peripheral Blood Mononuclear Cells From Healthy Subjects
NCT05560217 ·Status: UNKNOWN
-
A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers
NCT04313647 ·Status: COMPLETED ·Phase: PHASE1
-
Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)
NCT01291329 ·Status: COMPLETED ·Phase: PHASE2
-
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
NCT02336646 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease
NCT02287831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction
NCT01392105 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
NCT02171949 ·Status: UNKNOWN ·Phase: PHASE2
-
Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration
NCT01745731 ·Status: COMPLETED ·Phase: PHASE2